47 results
F-1
EX-5.1
IINN
Inspira Technologies Oxy B.H.N. Ltd
9 May 24
Registration statement (foreign)
5:02pm
the originals or copies, certified or otherwise identified to our satisfaction, of (i) the Registration Statement, to which this opinion is attached
F-1
EX-4.8
IINN
Inspira Technologies Oxy B.H.N. Ltd
9 May 24
Registration statement (foreign)
5:02pm
transaction or otherwise) or the Holder’s brokerage firm otherwise purchases, Ordinary Shares to deliver in satisfaction of a sale by the Holder
424B5
IINN
Inspira Technologies Oxy B.H.N. Ltd
1 Apr 24
Prospectus supplement for primary offering
4:01pm
supplement and accompanying prospectus is expected to be made on or about April 1, 2024, subject to satisfaction of customary closing conditions.
Prospectus
6-K
EX-10.1
IINN
Inspira Technologies Oxy B.H.N. Ltd
1 Apr 24
Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO’s Mother with Leading Fund Manager
8:46am
at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of Company … : (a) for the satisfaction of any portion of the Company’s debt (other than payment of trade payables in the ordinary course of the Company’s business and prior
6-K
EX-5.1
IINN
Inspira Technologies Oxy B.H.N. Ltd
1 Apr 24
Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO’s Mother with Leading Fund Manager
8:46am
examined the originals, or photocopies or copies, certified or otherwise identified to our satisfaction, of the Registration Statement, the Prospectus
6-K
EX-99.1
sug80w7icv11lc0f
1 Apr 24
Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO’s Mother with Leading Fund Manager
8:46am
S-8
EX-5.1
w2swxm1ffk82ghbv2
15 Mar 24
Registration of securities for employees
4:05pm
424B5
t0l1ctkiqas0jybobn
28 Dec 23
Prospectus supplement for primary offering
9:28am
6-K
EX-4.2
3grf4cqy
27 Dec 23
Inspira Announces $3.88 Million Registered Direct Offering
4:46pm
6-K
EX-10.1
j0e3dd
27 Dec 23
Inspira Announces $3.88 Million Registered Direct Offering
4:46pm
6-K
EX-4.1
9j85 epq8
27 Dec 23
Inspira Announces $3.88 Million Registered Direct Offering
4:46pm
6-K
EX-5.1
nzb6u6h7 czbg7knmq17
27 Dec 23
Inspira Announces $3.88 Million Registered Direct Offering
4:46pm
6-K
EX-99.1
dzedr4h3
27 Dec 23
Inspira Announces $3.88 Million Registered Direct Offering
4:46pm
6-K
EX-99.1
s51xt
29 Aug 23
Inspira™ Signs Agreement Expansion with Innovimed for Clinical Trials of INSPIRA™ ART Respiratory Medical Devices
4:36pm
6-K
EX-1.1
2qwfqs16 tkrwomysf
4 Apr 23
Report of Foreign Private Issuer
4:21pm
6-K
zrm7x1l
4 Apr 23
Report of Foreign Private Issuer
4:21pm
6-K
EX-5.1
p9ozapot tcrlf0h04jj
4 Apr 23
Report of Foreign Private Issuer
4:21pm
F-3
EX-5.1
nlpcs5g4 vwfk0fb
10 Aug 22
Shelf registration (foreign)
5:13pm